Gmma as an alternative carrier for a glycoconjugate vaccine against group a streptococcus

HIGHLIGHTS

• who: Elena Palmieri and colleagues from the GSK Institute for Global Health (GVGH), Via Fiorentina, Siena, ItalyDepartment of Chemical and Biological Engineering, The University of Sheffield, Mappin Street have published the research: GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus, in the Journal: Vaccines 2022, 1034 of 27/04/2022
• what: The authors explored the possibility of using GMMA as an alternative carrier system for GAC, comparing its immunogenicity to that of a more traditional glycoconjugate in different animal models. CRM197 as Carrier A process-modeling study was conducted to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.